We examined the expression level of FABP5 in RA-resistant TNBC cell lines (MDA-MB-231 and MDA-MB-468) in comparison to mammary carcinoma cells sensitive to RA-mediated growth suppression. Here, FABP5 is linked to breast carcinoma.